戊诺酰胺结构式
|
常用名 | 戊诺酰胺 | 英文名 | Valnoctamide |
|---|---|---|---|---|
| CAS号 | 4171-13-5 | 分子量 | 143.22700 | |
| 密度 | 0.883g/cm3 | 沸点 | 274.4ºC at 760mmHg | |
| 分子式 | C8H17NO | 熔点 | 113.5-114ºC | |
| MSDS | 中文版 美版 | 闪点 | 119.8ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
戊诺酰胺用途Valnoctamide (Valmethamide) 是一种 Valproate 的衍生物,可用于治疗对苯二氮卓类药物有抗药性的癫痫。Valnoctamide (Valmethamide) 直接作用于 GABAA 受体。 |
| 中文名 | 戊诺酰胺 |
|---|---|
| 英文名 | 2-ethyl-3-methyl-pentanamide Axiquel Nirvanil |
| 英文别名 | 更多 |
| 描述 | Valnoctamide (Valmethamide) 是一种 Valproate 的衍生物,可用于治疗对苯二氮卓类药物有抗药性的癫痫。Valnoctamide (Valmethamide) 直接作用于 GABAA 受体。 |
|---|---|
| 相关类别 | |
| 靶点 |
GABAA receptor[1] |
| 参考文献 |
| 密度 | 0.883g/cm3 |
|---|---|
| 沸点 | 274.4ºC at 760mmHg |
| 熔点 | 113.5-114ºC |
| 分子式 | C8H17NO |
| 分子量 | 143.22700 |
| 闪点 | 119.8ºC |
| 精确质量 | 143.13100 |
| PSA | 43.09000 |
| LogP | 2.24430 |
| InChIKey | QRCJOCOSPZMDJY-UHFFFAOYSA-N |
| SMILES | CCC(C)C(CC)C(N)=O |
| 折射率 | 1.438 |
|
~%
戊诺酰胺 4171-13-5 |
| 文献:Kaufmann, Dan; Bialer, Meir; Shimshoni, Jakob Avi; Devor, Marshall; Yagen, Boris Journal of Medicinal Chemistry, 2009 , vol. 52, # 22 p. 7236 - 7248 |
|
~%
戊诺酰胺 4171-13-5 |
| 文献:Freifelder,M. et al. Journal of Organic Chemistry, 1961 , vol. 26, p. 203 - 206 |
|
~%
戊诺酰胺 4171-13-5 |
| 文献:Kaufmann, Dan; Yagen, Boris; Minert, Anne; Wlodarczyk, Bogdan; Finnell, Richard H.; Schurig, Volker; Devor, Marshall; Bialer, Meir Neuropharmacology, 2010 , vol. 58, # 8 p. 1228 - 1236 |
|
~%
戊诺酰胺 4171-13-5 |
| 文献:Katznelson; Kondakowa Doklady Akademii Nauk SSSR, 1934 , p. II 24 Chem. Zentralbl., 1935 , vol. 106, # I p. 2521 |
|
~%
戊诺酰胺 4171-13-5 |
| 文献:Katznelson; Kondakowa Doklady Akademii Nauk SSSR, 1934 , p. II 24 Chem. Zentralbl., 1935 , vol. 106, # I p. 2521 |
| 海关编码 | 2924199090 |
|---|---|
| 中文概述 | 2924199090. 其他无环酰胺(包括无环氨基甲酸酯)(包括其衍生物及盐). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途, 包装 |
| Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
Pharm. Res. 17(2) , 216-21, (2000) The purpose of this study was to evaluate the in vitro inhibitory potency of various amide analogues and derivatives of valproic acid toward human microsomal epoxide hydrolase (mEH).mEH inhibition was... |
|
|
A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus.
Neuroscience 231 , 145-56, (2013) Better treatment of status epilepticus (SE), which typically becomes refractory after about 30 min, will require new pharmacotherapies. The effect of sec-butyl-propylacetamide (SPD), an amide derivati... |
|
|
Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
Birth Defects Res. B Dev. Reprod. Toxicol. 71(1) , 47-53, (2004) The antiepileptic drug valproic acid (VPA) is well known to cause neural tube and skeletal defects in both humans and animals. The amidic VPA analogues valpromide (VPD) and valnoctamide (VCD) have muc... |
| 2-ethyl-3-methylpentanamide |
| Valnoctamide |